RVO
HomeMarketplace

PartnershipUpdated on 1 September 2025

Partnership opportunities in advanced targeted therapies for cancer

Rositsa Jordanova

CEO and founder at Protyon

Groningen, Netherlands

About

Protyon is seeking partnership opportunities with organizations developing advanced targeted therapies. We are especially interested in exploring new avenues and cancer drivers beyond non-small cell lung cancer.

We can de-risk development pipelines by assessing novel mutations, supporting drug efficacy evaluation, and enhancing cohort selection to increase clinical trial success. With particular expertise in tyrosine kinase inhibitors (EFGR, BRAF, ALK), we help partners optimize patient selection and minimize unsuccessful treatments.

Organisation

Protyon

Company

Groningen, Netherlands

Similar opportunities